Potential clinical use of differentiated cells from embryonic or Mesenchymal stem cells in orthopeadic problems

Curr Stem Cell Res Ther. 2015 Mar 31. Online ahead of print.

Abstract

Stem cells are classified by their tissue source. Embryonic stem cells that derived from inner cell mass of blastocyst stage embryos are highly proliferative in their undifferentiated state. A multipotent type of mesenchymal stem cells isolated from different type of tissues such as bone marrow, fat tissue etc. The dynamics of embryonic and adult stem cell cycles are profoundly dissimilar than the culture of stem cells. After improving the culture conditions and differentiation potentials, differentiated stem cells are the first cells to be preferred in modern regenerative medicine and tissue engineering. This review article focuses on the cell-based therapy on orthopedic problems. We explore the challenges associated with bone repair and regeneration using embryonic or mesenchymal stem cells that use undifferentiated or/and differentiated condition. This paper also discusses optimizing the best cell type, differentiation condition and using them on bone tissue engineering in future investigation.